Green Lumber Natural Fuel For Men Capsules Recalled as Unapproved Drug
Green Lumber Natural Fuel For Men capsules are recalled because FDA determined the product was marketed without required approval and contains the active ingredient tadalafil.
What this means for you
Highest-severity recall. Risk of serious injury or death is documented or strongly suspected. Stop using the product now and follow the agency's instructions.
Our severity reasoning: FDA Class I recalls are classified as Critical per the severity rubric. This product was marketed without required FDA approval and contains an active pharmaceutical ingredient.
Plain-English summary
Green Lumber Natural Fuel For Men capsules, sold in 2, 4, 10, and 30-count blister packs, are being recalled. FDA determined that the product was marketed without required FDA approval and contains tadalafil, an active pharmaceutical ingredient.
The product was distributed nationwide. This is an FDA Class I recall, the most serious category. Consumers should stop using this product immediately and discard remaining doses.
Retailers and distributors should remove this product from shelves. The recalling firm is Green Lumber Holdings, LLC, located at 2618 San Miguel Drive, Suite #296, Newport Beach, CA 92660.
The recalled product
- Product
- Green Lumber Natural Fuel For Men capsule, packaged in 2, 4, 10, and 30-count blister packs. GreenLumber.com, 2618 San Miguel Drive, Suite #296, Newport Beach, CA 92660
- Manufacturer
- Green Lumber Holdings, LLC
- Category
- Drug
- Hazard
- unapproved-drug
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- LOT308EXP03/28
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowBusulfan Injection Recalled for Failed Impurities and Degradation Specifications
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27